CGH analysis of ductal carcinoma of the breast with basaloid/myoepithelial cell differentiation - PubMed (original) (raw)

Comparative Study

. 2001 Aug 3;85(3):422-7.

doi: 10.1054/bjoc.2001.1869.

Affiliations

Free PMC article

Comparative Study

CGH analysis of ductal carcinoma of the breast with basaloid/myoepithelial cell differentiation

C Jones et al. Br J Cancer. 2001.

Free PMC article

Abstract

2-18% of ductal carcinoma-No Special Type (NST) are reported to express basal cell keratin 14 and such tumours may have a different metastatic pattern and prognosis. We performed immunohistochemistry for cytokeratins 19 (luminal) and 14 (basal) on 92 ductal carcinoma-NST. Those tumours showing CK14 expression were further characterized by immunohistochemistry for myoepithelial cell phenotype and analysed by comparative genomic hybridization. The 7 cases of ductal carcinoma-NST exhibiting a basal cell phenotype were all grade III tumours and showed a molecular cytogenetic profile similar to more conventional myoepithelial cell carcinomas. Therefore it appears that grade III invasive ductal carcinomas contain a subset of tumours with specific morphological and cytogenetic characteristics, and probably prognosis for the patient.

Copyright 2001 Cancer Research Campaign.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Virchows Arch. 1999 Nov;435(5):520-3 - PubMed
    1. J Clin Pathol. 1995 Feb;48(2):164-7 - PubMed
    1. Int J Cancer. 1988 Aug 15;42(2):147-53 - PubMed
    1. Nature. 2000 Aug 17;406(6797):747-52 - PubMed
    1. Am J Surg Pathol. 1982 Dec;6(8):785-93 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources